Quick Search


 

ViiV Healthcare-sponsored clinical studies are those for which ViiV Healthcare is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ViiV Healthcare-sponsored clinical trials are those for which ViiV Healthcare is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Find a protocol summary

The Register provides summary protocol information for clinical studies (of ViiV Healthcare medicines) for which ViiV Healthcare (or GSK) was the regulatory sponsor. Clinical studies are categorised as recruiting, not yet recruiting, no longer recruiting, terminated, or completed.

Find a result summary

The Register provides scientific, non-promotional summaries of clinical studies in a consistent format, irrespective of whether the results may be viewed as positive or negative for ViiV Healthcare medicines. The Register includes clinical studies of marketed products and other studies that are relevant to patient care.

About the ViiV Healthcare Clinical Study Register

The ViiV Healthcare Clinical Study Register provides an easily accessible repository of data from clinical studies of ViiV Healthcare medicines, for which ViiV Healthcare (or GSK) was the regulatory sponsor, supplementing communication in journals, at scientific meetings, in letters to healthcare professionals, and in approved prescribing information. It is important to emphasise that approved prescribing information must continue to guide appropriate use of ViiV Healthcare medicines. This information may vary from country to country. Before prescribing any product mentioned in the Register, Healthcare Professionals should consult prescribing information approved in their country.

ViiV Healthcare: Our History

ViiV Healthcare was established by GlaxoSmithKline and Pfizer in 2009 to focus exclusively on delivering advances in treatment and care for people living with HIV. Shionogi joined ViiV Healthcare in 2012. As a result, one of our shareholders was the regulatory sponsor for many clinical studies of ViiV Healthcare medicines, and therefore the results of such studies may not appear on this register. Please see other public registries such as www.ClinicalTrials.gov or EU Clinical Trials Register for any study disclosures from our shareholders.